Physician profile

David Streets

Orthopaedic Surgery · Olney, MD

NPI 1881892172

$4,996.56

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$645.76

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Supreme Orthopedic Systems, LLC $4,193.94 2019-2023
Stryker Corporation $182.66 2022-2023 Iconix, Procinch
Smith+Nephew, INC. $176.84 2019-2023 Polarstem, Ri Hip Navigation, Or3o Dual Mobility
Medical Device Business Services, INC. $149.62 2024 Attune, Velys
Zimmer Biomet Holdings, INC. $143.52 2023 Wrist Fusion Pins
Miach Orthopaedics, INC. $122.64 2024
Depuy Synthes Sales INC. $27.34 2023 Actis, Attune

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

David Streets

$4,996.56

in general payments reported 2019-2025

Years
2019-2024
Top company
Supreme Orthopedic Systems, LLC

https://glasscript.com/doctor/221960/david-streets

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.